MetLife Investment Advisors »

Nektar Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $139k 107k 1.30
2024-06-30 $58k 47k 1.24
2023-03-31 $43k 61k 0.70
2022-12-31 $215k 95k 2.26
2022-09-30 $304k 95k 3.20
2022-06-30 $361k 95k 3.80
2022-03-31 $19k 3.6k 5.39
2021-09-30 $1.6M 88k 17.96
2021-06-30 $1.6M 91k 17.16
2021-03-31 $1.9M 94k 20.00
2020-12-31 $1.7M 98k 17.00
2020-09-30 $1.7M 102k 16.59
2020-06-30 $2.4M 106k 23.16
2020-03-31 $1.8M 101k 17.85
2019-12-31 $2.2M 101k 21.59
2019-09-30 $869k 48k 18.22
2019-06-30 $1.7M 48k 35.57
2019-03-31 $1.6M 50k 32.71
2018-12-31 $1.6M 50k 32.87
2018-09-30 $3.1M 50k 60.96
2018-06-30 $2.3M 47k 48.83
2018-03-31 $12M 115k 106.26
2017-12-31 $4.0M 67k 59.72